menopause and glp 1 GLP-1 Medications Their Role In Weight Gain Starting a GLP-1 in Perimenopause

1 However, notable weaknesses include poor oral bioavailability, rapid enzymatic degradation, short half-lives, and the need for parenteral administration in many cases

Its selective action on growth hormone release helps to regenerate muscle tissue supporting both recovery and development of new muscle fibers

[12] [13] [91] In February 2026, a French man, Jean-Marc Laurent, filed what has been described as the first legal complaint related to paternal exposure to valproate, alleging that his child developed neurodevelopmental disorders after he had been treated with the drug prior to conception

Use it (fat) to lose it (well)

But the idea of possibly avoiding surgery made me willing to try something new